ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 189 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $3,705,000 | +690.0% | 39,846 | +553.0% | 0.01% | +133.3% |
| Q4 2020 | $469,000 | -9.1% | 6,102 | -11.6% | 0.00% | 0.0% |
| Q3 2020 | $516,000 | -74.7% | 6,899 | -78.7% | 0.00% | -78.6% |
| Q2 2020 | $2,042,000 | -80.3% | 32,445 | -85.8% | 0.01% | -80.3% |
| Q4 2019 | $10,369,000 | -9.8% | 228,307 | -9.1% | 0.07% | -21.1% |
| Q3 2019 | $11,491,000 | +599.0% | 251,052 | +795.0% | 0.09% | +542.9% |
| Q2 2019 | $1,644,000 | +270.3% | 28,051 | +183.3% | 0.01% | +600.0% |
| Q1 2019 | $444,000 | -86.5% | 9,900 | -88.3% | 0.00% | -94.1% |
| Q4 2018 | $3,299,000 | +1010.8% | 84,687 | +1142.5% | 0.03% | +750.0% |
| Q2 2018 | $297,000 | +35.6% | 6,816 | +23.1% | 0.00% | -55.6% |
| Q1 2018 | $219,000 | – | 5,538 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 163,133 | $7,467,000 | 4.14% |
| PFM Health Sciences, LP | 2,271,536 | $103,968,000 | 3.07% |
| Partner Investment Management, L.P. | 28,877 | $1,322,000 | 2.26% |
| Atika Capital Management LLC | 181,000 | $8,284,000 | 1.74% |
| DAFNA Capital Management LLC | 93,942 | $4,300,000 | 1.62% |
| Asymmetry Capital Management, L.P. | 16,272 | $745,000 | 1.60% |
| First Light Asset Management, LLC | 190,838 | $8,735,000 | 1.32% |
| Perceptive Advisors | 953,129 | $43,624,000 | 1.18% |
| Rhenman & Partners Asset Management AB | 155,000 | $7,094,000 | 0.89% |
| Opus Point Partners Management, LLC | 9,770 | $447,000 | 0.81% |